https://kuraoncology.com/wp-content/uploads/pharma_voice_gears.jpeg450800eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2023-05-18 08:00:542023-05-23 13:57:17What pharma can teach biotech about the life cycle management of a drug
https://kuraoncology.com/wp-content/uploads/BioCentury_0201_DB_DoseOptim.png6461246David Anderson/wp-content/uploads/kura-logo-registered-blue.svgDavid Anderson2023-02-01 08:00:002023-02-07 14:03:52Navigating dose optimization requirements as a small biotech
https://kuraoncology.com/wp-content/uploads/LiquidBiopsies_GettyImages-1325872227-1068x712-1.jpg7121068David Anderson/wp-content/uploads/kura-logo-registered-blue.svgDavid Anderson2022-09-06 14:25:062023-01-05 12:40:46Liquid Biopsies Guide the Development of Cancer Drugs
https://kuraoncology.com/wp-content/uploads/Kura_Dawn-of-Medicine-Article-img-scaled.jpeg17092560David Anderson/wp-content/uploads/kura-logo-registered-blue.svgDavid Anderson2021-04-20 06:00:022022-11-16 13:25:55Journal of Clinical Oncology: Is This the Dawn of Precision Oncology in Head and Neck Cancer?